EKSO Bionics Holdings, Inc. has entered into a merger agreement to combine with Applied Digital’s GPU Cloud business, creating a new publicly traded entity named ChronoScale. The transaction, expected to close in the first half of 2026, will be structured as a reverse merger in which Applied Digital contributes its cloud division to EKSO in exchange for newly issued EKSO shares. Upon closing, existing EKSO shareholders will own approximately 40% of ChronoScale, with Applied Digital shareholders holding the remaining 60%. The deal aims to unlock value by separating EKSO’s bionics operations from the high-growth GPU cloud market. EKSO management forecasts that the pro forma company will benefit from a combined contracted backlog exceeding $1.5 billion and will have access to EKSO’s balance sheet and equity platform to fund future infrastructure expansion. Investors will be monitoring the timeline for regulatory approvals, the exact share exchange ratio, and how EKSO intends to deploy the net proceeds—estimated at $200 million—to accelerate product development in both its robotics and cloud divisions.